In particular, studies have confirmed that cyclooxygenase (COX), typically the inducible form of COX-2, is commonly overexpressed in lung cancer and the abundance of its enzymatic product prostaglandin E2 (PGE2) plays an important role in influencing cancer development. This evidence concerns the gene PTGS2 and lung carcinoma.